The DCIR/LRP1 axis in myeloid cells: A new target in immunity to tuberculosis?
Tamara Sneperger, IPBS, CNRS (France)
Extracellular vesicles released during Mycobacterium tuberculosis infection: bacterial lipid content and roles in host-pathogen interactions
Emilie Layre, IPBS, CNRS (France)
Blood RNA signatures of the adjunctive administration of cyclooxygenase-2-inhibitor (Etericoxib) or therapeutic vaccine candidate (H56:IC31) in TB disease
Noelia Alonso-Rodriguez, Oslo University Hospital (Norway)
Mucosal vaccination with MTBVAC displays improved induction of trained immunity and broadened local adaptive immune signatures (poster)
Michel Vierboom, BPRC (Netherlands)
Mycobacterium tuberculosis genetic features associated with pulmonary tuberculosis severity (poster)
Charlotte Genestet, Centre International de Recherche en Infectiologie [CIRI], Hospices Civils de Lyon (France)
Comparison of three methods of Mycobacterium tuberculosis complex spoligotype determination for clinical isolates (poster)
Charlotte Genestet, Centre International de Recherche en Infectiologie [CIRI], Hospices Civils de Lyon (France)
Exploring different routes of Vaccination against tuberculosis with parental and recombinant BCG vaccines in murine models
Fadel Sayes, Institute Pasteur (France)
Diet and hyperglycaemia affect vaccine immunogenicity and efficacy in mice (poster)
Elena Stylianou, University of Oxford (UK)
An adjuvant system based on a mesoporous silica particle with a mycobacterial surface lipid bilayer (poster)
Carlos M. Valdemar-Aguilar, Universidad National Autonoma de Mexico (Mexico)
PPM, a potential candidate for RNA vaccine to prevent active TB disease
Chaouki Benabdessalem, Institut Pasteur de Tunis (Tunisia)
The evaluation of a new recombinant BCG vaccine in cynomolgus macaque model
Natsuko Yamakawa (Japan)
BCG-primed HEHR/CIA09A boosted vaccination mediated improved protection against hypervirulent Mycobacterium tuberculosis strain M2 in mice by eliciting antigen-specific Th1 and Th17 responses
Kee Woong Kwon, Yonsei University (South Korea)
Pulmonary immunity and durable protection induced by the multiantigenic subunit vaccine candidate composed of Rv0351/Rv3628 against the hypervirulent Mycobacterium tuberculosis strain K
Kee Woong Kwon, Yonsei University (South Korea)
Deciphering lysosomal enzymatic activities involved in the processing of mycobacterial antigenic glycolipids
Sonia Belkai, IPBS, CNRS (France)
Development of Novel Autophagy-Prone BCG Strains as Live Vaccines
Isabelle Vergne, IPBS, CNRS (France)
A tractable and accessible method for generating human Alveolar Macrophage Like (AML) cells in vitro: a new breakthrough in lung biology
Susanta Pahari, Texas Biomedical Research Institute (USA)
Safety and reactogenicity of MTBVAC and BCG vaccines in South African adults
Angelique Luabeya Kany Kany, SATVI (South Africa)
Influence of aerosol delivered BCG vaccination on immunological and disease parameters following SARS-CoV-2 challenge in rhesus macaques
Laura Sibley, UK Health Security Agency (UK)
